Literature DB >> 30785863

Bridging the Gap Between Remission and Recovery in BPD: Qualitative Versus Quantitative Perspectives.

Paul H Soloff1.   

Abstract

The 10-year outcome for patients with borderline personality disorder (BPD) is diagnostic remission in 85% to 93%; however, less than half achieve good social and vocational functioning, and few attain full psychosocial recovery. To assess the gap between diagnostic remission and psychosocial recovery, quantitative measures of outcome were compared with narrative reports of psychosocial functioning in 150 BPD subjects followed prospectively from 2 to 31 years (mean 9.94 years). Subjects with the best and the worst outcomes were compared on symptom changes over time, and on efforts to improve psychosocial functioning. At intake, poor outcome subjects were more impaired than those with good outcomes, with more borderline psychopathology, hospitalizations, and poverty. At follow-up, 53.8% of good outcome subjects complained of continuing problems with depression, 33.3% with anger and impulse control, and 25.6% with unstable relationships. Despite objective measures of improvement, narrative reports documented residual BPD symptoms, comorbidity, and unemployment interfering with psychosocial recovery.

Entities:  

Keywords:  borderline personality disorder; diagnostic remission; psychosocial recovery

Year:  2019        PMID: 30785863      PMCID: PMC9237745          DOI: 10.1521/pedi_2019_33_419

Source DB:  PubMed          Journal:  J Pers Disord        ISSN: 0885-579X


  41 in total

1.  An inventory for measuring depression.

Authors:  A T BECK; C H WARD; M MENDELSON; J MOCK; J ERBAUGH
Journal:  Arch Gen Psychiatry       Date:  1961-06

2.  FACTOR ANALYSIS OF SOME PSYCHOMETRIC MEASURES OF IMPULSIVENESS AND ANXIETY.

Authors:  E S BARRATT
Journal:  Psychol Rep       Date:  1965-04

3.  An inventory for assessing different kinds of hostility.

Authors:  A H BUSS; A DURKEE
Journal:  J Consult Psychol       Date:  1957-08

4.  Reasons for staying alive when you are thinking of killing yourself: the reasons for living inventory.

Authors:  M M Linehan; J L Goodstein; S L Nielsen; J A Chiles
Journal:  J Consult Clin Psychol       Date:  1983-04

5.  The diagnostic interview for borderline patients.

Authors:  J G Gunderson; J E Kolb; V Austin
Journal:  Am J Psychiatry       Date:  1981-07       Impact factor: 18.112

6.  Rates of psychotropic medication use reported by borderline patients and axis II comparison subjects over 16 years of prospective follow-up.

Authors:  Mary C Zanarini; Frances R Frankenburg; D Bradford Reich; Alayna L Harned; Garrett M Fitzmaurice
Journal:  J Clin Psychopharmacol       Date:  2015-02       Impact factor: 3.153

7.  Fluidity of the Subsyndromal Phenomenology of Borderline Personality Disorder Over 16 Years of Prospective Follow-Up.

Authors:  Mary C Zanarini; Frances R Frankenburg; D Bradford Reich; Garrett M Fitzmaurice
Journal:  Am J Psychiatry       Date:  2016-02-12       Impact factor: 18.112

8.  Prospective assessment of treatment use by patients with personality disorders.

Authors:  Donna S Bender; Andrew E Skodol; Maria E Pagano; Ingrid R Dyck; Carlos M Grilo; M Tracie Shea; Charles A Sanislow; Mary C Zanarini; Shirley Yen; Thomas H McGlashan; John G Gunderson
Journal:  Psychiatr Serv       Date:  2006-02       Impact factor: 3.084

9.  Ten-year use of mental health services by patients with borderline personality disorder and with other axis II disorders.

Authors:  Susanne Hörz; Mary C Zanarini; Frances R Frankenburg; D Bradford Reich; Garrett Fitzmaurice
Journal:  Psychiatr Serv       Date:  2010-06       Impact factor: 3.084

10.  Prediction of time-to-attainment of recovery for borderline patients followed prospectively for 16 years.

Authors:  M C Zanarini; F R Frankenburg; D B Reich; M M Wedig; L C Conkey; G M Fitzmaurice
Journal:  Acta Psychiatr Scand       Date:  2014-03-04       Impact factor: 6.392

View more
  1 in total

1.  Personal agency and borderline personality disorder: a longitudinal study of outcomes.

Authors:  Talia Hashworth; Samantha Reis; Michelle Townsend; Jessica O 'Garr; Brin F S Grenyer
Journal:  BMC Psychiatry       Date:  2022-08-22       Impact factor: 4.144

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.